124i-mu 11-1f4
mAbexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2008 (NCT01409148)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Beta amyloid A4 proteinImmunity, passive
APP immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 124-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 124i-mu 11-1f4
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00807872 | Phase 1 | Dec 1, 2008 | Food and Drug Administration, University of Tennessee |
| NCT01409148 | Phase 1 | Nov 1, 2008 | Food and Drug Administration, University of Tennessee |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Food and Drug Administration | Government | 2 | 0 | 1 | 2008 |
| University of Tennessee | Academic/Hospital | 2 | 2 | 1 | 2008 |
2 organizations
Page 1 / 1